Ross Chikarmane
InvestorAssociate at RA Capital
Boston, Massachusetts
Writes $100K checks Β· typically $100K
About
Ross Chikarmane is a biotech investor and scientist with experience at RA Capital, where he evaluated investment opportunities across metabolic, cardiology, and kidney disease companies and supported the creation of new companies in orphan enzyme replacement therapy and genetic kidney disease. He holds a PhD in Pharmacology from Johns Hopkins School of Medicine, where his research focused on prostate cancer genomics and drug discovery, and he previously worked with Johns Hopkins Technology Ventures on research commercialization.
Experience
- RA Capital Management, L.P.Healthcare Associate2022 β 2025Boston, Massachusetts, United States
- RA Capital Management, L.P.TechAtlas Intern2021 β 2022Boston, Massachusetts, United States
- The Johns Hopkins University School of MedicinePhD Candidate, Lab of Vasan Yegnasubramanian/William Nelson2017 β 2022Cancer Research Building II, 1550 Orleans St, Baltimore, MD 21287
- The Johns Hopkins University School of MedicineBiotech Journalist, Biomedical Odyssey2018 β 2021733 N Broadway, Baltimore, MD 21205
- The Johns Hopkins University School of MedicineGraduate Rotation Student, Lab of Jonathan Powell2017Cancer Research Building I, 1550 Orleans St, Baltimore, MD 21287
- Johns Hopkins Technology Ventures (JHTV)Analyst, Commercialization Academy2020 β 2021Baltimore, Maryland, United States
- Hopkins Biotech PodcastFounder & Director2020 β 2021Baltimore, Maryland, United States
- Hopkins Biotech NetworkCo-Director of Alumni Relations, Hopkins Biotech Network (HBN)2020 β 2021Baltimore, Maryland Area
- University of OregonUndergraduate Research Assistant, Lab of Clifford Kentros Laboratory2014 β 20171585 E 13th Ave, Eugene, OR 97403
- University of OregonOrganic Chemistry Teaching Assistant (SUPeR Chem PLA)2014 β 20171585 E 13th Ave, Eugene, OR 97403
- American Chemical SocietyTreasurer of Student Affiliates of the American Chemical Society (SAACS)2015 β 2016University of Oregon
- University of OregonUndergraduate Research Assistant, Lab of Mike Harms2013 β 20141585 E 13th Ave, Eugene, OR 97403
- Avamere at Bethany, Senior Assisted LivingDietary/Nutritional Service Staff201316360 NW Avamere Ct, Portland, OR
Skills & more
EMR2PowerPoint4Microsoft Word2Microsoft Office3Microsoft Excel2Public Speaking5Leadership4Hospitals7Nursing7Critical Care3Physicians4Clinical Research6
+12 more
Cpr CertifiedTreatmentPublic HealthMedical/SurgicalLaboratoryICUHealthcare Information TechnologyPatient SafetyHealthcareMedical TerminologyResearchData AnalysisFrom Ross's professional profile.
Colleagues at RA Capital
Abigail Schmitz
Senior Associate, Corporate Development at RA Capital
Adam Kaye
Senior Managing Director and Partner, Structured Capital at RA Capital
Adrian Bot
Venture Partner at RA Capital
Albert Kim
Advisor at RA Capital
Alex Miller
Senior Associate, Venture at RA Capital
Alex Zhang
Vice President, Structured Capital at RA Capital
Alison Tisdale
Advisor at RA Capital
Alyssa Larson
Investor at RA Capital
Frequently asked questions
- Who is Ross Chikarmane?
- Ross Chikarmane is a biotech investor and scientist with experience at RA Capital, where he evaluated investment opportunities across metabolic, cardiology, and kidney disease companies and supported the creation of new companies in orphan enzyme replacement therapy and genetic kidney disease. He holds a PhD in Pharmacology from Johns Hopkins School of Medicine, where his research focused on prostate cancer genomics and drug discovery, and he previously worked with Johns Hopkins Technology Ventures on research commercialization.
- Where does Ross Chikarmane work?
- Ross Chikarmane is Associate at RA Capital.
- What check size does Ross Chikarmane write?
- Ross Chikarmane typically writes checks of $100K.
- Where did Ross Chikarmane go to school?
- Ross Chikarmane studied at The Johns Hopkins University School of Medicine (PhD, Pharmacology & Molecular Sciences); University of Oregon (Bachelor of Science (B.S.), Biochemistry with Honors).
Same school
Also attended The Johns Hopkins University School of Medicine28
Hal PazInvestor at Khosla VenturesRochelle WalenskyExecutive Partner at Flare Capital PartnersBeth SeidenbergFounding Managing Director at Westlake Village BioPartnersS.K. LeeExecutive Coach at Roble VenturesKayarash KarimianSenior Associate at Cure VenturesSamantha GuinnAnalyst at Novartis Venture Fund
+ 22 more
Also attended University of Oregon66
Darcy YeeMarketing and Communications at Menlo VenturesJessica YuSenior Finance Associate at GreycroftIsabelle SmithEvents Coordinator at HeavybitJennifer SavagePartner at Illuminate VenturesTilak MandadiExecutive Vice President, Ventures and Chief Experience and Technology at Flare Capital PartnersKrista CoppermanOperating Partner at TCV
+ 60 more
Shared employers
Also worked at The Johns Hopkins University School of Medicine13
Yoola AdenijiSenior Associate at LRVHealthRobert LordVenture Partner at LionBirdLuc StarmansPartner at Brightlands Venture PartnersMatthew HobsonPrincipal at Catalio Capital Management, LPMichelle LevinePrincipal at Solasta VenturesDoug KerrScience Advisor at Exceptional Ventures
+ 7 more
Also worked at Johns Hopkins Technology Ventures (JHTV)6
Jeffrey CherryFounder at Conscious Venture LabMelissa FensterstockCompany Building Advisor at Material ImpactChandra RamanathanAdvisor, Biotech at Iaso VenturesIsabelle HoltPlatform Associate, Network at Inspired CapitalGraham DodgeVice President, Venture Development at Maryland TEDCOLanre OgungbeFounder at Prembly (formerly Identitypass)
Also worked at University of Oregon7
Stephen Bryon McKeonManaging Partner at Collab+CurrencyEthan UeckerAssociate at Banneker PartnersLauren WitherspoonCommunications & Events Manager at Nyca PartnersNikhil ShahFounder at Slidely AIBerkley NobleFounder/CTO at DuraniumBethany JenkinsBoard Director; VP for Research & Economic Development, URI at Slater Technology Fund
+ 1 more


















.png)





















